The anti-tumor activity of the combination of Chk1 and wee1 inhibitors has been tested in several previous reports [19, 51–55], generally indicating that the combination produces a synergistic effect on tumor cell proliferation or viability. The gene discussed is WEE1; the disease is neoplasm.